Y3U-22849-09156
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 190 / PA
- Registered
- 2022-12-18
- Relationship
- Child or adolescent in my care
- Guardian
- 3FN-30985-06428
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-15
Dose 1 — ModernaCo-administered: Hepatitis B
-
2022-12-18
Registered in v-safe
- 2022-12-18
- 2022-12-19
-
2022-12-20
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Poor · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-12-21
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-12-22
Survey response — day 7, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-29
- 2023-01-05
- 2023-01-12
-
2023-01-16
Dose 2 — Moderna
- 2023-01-19
- 2023-01-20
- 2023-01-21
- 2023-01-22
- 2023-01-23
- 2023-01-30
- 2023-02-06
- 2023-02-13
- 2023-02-22
- 2023-02-27
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-15 | Moderna | Hepatitis B |
| 2 | 2023-01-16 | Moderna | No |
Free text
Release 12 (Under 3) — day 7, dose 1, under 3
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release